SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-135312
Filing Date
2020-05-07
Accepted
2020-05-07 06:03:28
Documents
47
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d848605d10q.htm   iXBRL 10-Q 931368
2 EX-31.1 d848605dex311.htm EX-31.1 8725
3 EX-31.2 d848605dex312.htm EX-31.2 8728
4 EX-32.1 d848605dex321.htm EX-32.1 6297
  Complete submission text file 0001193125-20-135312.txt   3364729

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20200331.xsd EX-101.SCH 23011
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mdgl-20200331_cal.xml EX-101.CAL 24148
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mdgl-20200331_def.xml EX-101.DEF 71757
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20200331_lab.xml EX-101.LAB 207694
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20200331_pre.xml EX-101.PRE 155661
20 EXTRACTED XBRL INSTANCE DOCUMENT d848605d10q_htm.xml XML 547995
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 20854360
SIC: 2834 Pharmaceutical Preparations